ATX_ASPTN
ID ATX_ASPTN Reviewed; 1803 AA.
AC Q0CJ59;
DT 02-NOV-2016, integrated into UniProtKB/Swiss-Prot.
DT 17-OCT-2006, sequence version 1.
DT 03-AUG-2022, entry version 88.
DE RecName: Full=6-methylsalicylic acid synthase {ECO:0000303|PubMed:9003280};
DE Short=6-MSAS {ECO:0000303|PubMed:9003280};
DE EC=2.3.1.165 {ECO:0000269|PubMed:9003280};
DE AltName: Full=Polyketide synthase atX {ECO:0000305};
DE AltName: Full=Terreic acid biosynthesis protein X {ECO:0000303|PubMed:9003280};
GN Name=atX {ECO:0000303|PubMed:9003280};
GN Synonyms=pksM {ECO:0000303|PubMed:9438344}; ORFNames=ATEG_06275;
OS Aspergillus terreus (strain NIH 2624 / FGSC A1156).
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus;
OC Aspergillus subgen. Circumdati.
OX NCBI_TaxID=341663;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=NIH 2624 / FGSC A1156;
RA Birren B.W., Lander E.S., Galagan J.E., Nusbaum C., Devon K., Henn M.,
RA Ma L.-J., Jaffe D.B., Butler J., Alvarez P., Gnerre S., Grabherr M.,
RA Kleber M., Mauceli E.W., Brockman W., Rounsley S., Young S.K., LaButti K.,
RA Pushparaj V., DeCaprio D., Crawford M., Koehrsen M., Engels R.,
RA Montgomery P., Pearson M., Howarth C., Larson L., Luoma S., White J.,
RA Alvarado L., Kodira C.D., Zeng Q., Oleary S., Yandava C., Denning D.W.,
RA Nierman W.C., Milne T., Madden K.;
RT "Annotation of the Aspergillus terreus NIH2624 genome.";
RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN [2]
RP FUNCTION, AND CATALYTIC ACTIVITY.
RX PubMed=9003280; DOI=10.1007/s004380050289;
RA Fujii I., Ono Y., Tada H., Gomi K., Ebizuka Y., Sankawa U.;
RT "Cloning of the polyketide synthase gene atX from Aspergillus terreus and
RT its identification as the 6-methylsalicylic acid synthase gene by
RT heterologous expression.";
RL Mol. Gen. Genet. 253:1-10(1996).
RN [3]
RP FUNCTION, AND INDUCTION.
RX PubMed=9438344; DOI=10.1007/bf02826548;
RA Pazoutova S., Linka M., Storkova S., Schwab H.;
RT "Polyketide synthase gene pksM from Aspergillus terreus expressed during
RT growth phase.";
RL Folia Microbiol. (Praha) 42:419-430(1997).
RN [4]
RP BIOTECHNOLOGY.
RX PubMed=10051623; DOI=10.1073/pnas.96.5.2227;
RA Kawakami Y., Hartman S.E., Kinoshita E., Suzuki H., Kitaura J., Yao L.,
RA Inagaki N., Franco A., Hata D., Maeda-Yamamoto M., Fukamachi H., Nagai H.,
RA Kawakami T.;
RT "Terreic acid, a quinone epoxide inhibitor of Bruton's tyrosine kinase.";
RL Proc. Natl. Acad. Sci. U.S.A. 96:2227-2232(1999).
RN [5]
RP BIOTECHNOLOGY.
RX PubMed=23686727; DOI=10.1002/jobm.201200617;
RA Olesen S.H., Ingles D.J., Yang Y., Schoenbrunn E.;
RT "Differential antibacterial properties of the MurA inhibitors terreic acid
RT and fosfomycin.";
RL J. Basic Microbiol. 54:322-326(2014).
RN [6]
RP FUNCTION.
RX PubMed=24534845; DOI=10.1016/j.jbiotec.2014.01.038;
RA Boruta T., Bizukojc M.;
RT "Culture-based and sequence-based insights into biosynthesis of secondary
RT metabolites by Aspergillus terreus ATCC 20542.";
RL J. Biotechnol. 175:53-62(2014).
RN [7]
RP FUNCTION, AND DISRUPTION PHENOTYPE.
RX PubMed=25265334; DOI=10.1021/ol502242a;
RA Guo C.J., Sun W.W., Bruno K.S., Wang C.C.;
RT "Molecular genetic characterization of terreic acid pathway in Aspergillus
RT terreus.";
RL Org. Lett. 16:5250-5253(2014).
CC -!- FUNCTION: 6-methylsalicylic acid synthase; part of the gene cluster
CC that mediates the biosynthesis of terreic acid, a quinone epoxide
CC inhibitor of Bruton's tyrosine kinase (PubMed:24534845,
CC PubMed:25265334). The first step of the pathway is the synthesis of 6-
CC methylsalicylic acid (6-MSA) by the 6-methylsalicylic acid synthase atX
CC (PubMed:9003280, PubMed:9438344, PubMed:25265334). In the biosynthesis
CC of 6-MSA, atX utilizes one acetyl-CoA and three malonyl-CoAs as its
CC substrates and catalyzes a series of programmed reactions including
CC Claisen condensation, dehydration, reduction, and cyclization to yield
CC 6-MSA (PubMed:9003280, PubMed:9438344, PubMed:25265334). The 6-
CC methylsalicylic acid decarboxylase atA then catalyzes the
CC decarboxylative hydroxylation of 6-MSA to 3-methylcatechol
CC (PubMed:25265334). The next step is the conversion of 3-methylcatechol
CC to terremutin via several oxidation steps involving the cytochrome P450
CC monooxygenase atE and probably also the cytochrome P450 monooxygenase
CC atG (PubMed:25265334). Lastly, atC is required for the oxidation of
CC terremutin to terreic acid (PubMed:25265334). No function could be
CC assigned to atD yet, although it is involved in the biosynthesis of
CC terreic acid (PubMed:25265334). {ECO:0000269|PubMed:25265334,
CC ECO:0000269|PubMed:9003280, ECO:0000269|PubMed:9438344,
CC ECO:0000305|PubMed:24534845}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=acetyl-CoA + 3 H(+) + 3 malonyl-CoA + NADPH = 6-
CC methylsalicylate + 3 CO2 + 4 CoA + H2O + NADP(+);
CC Xref=Rhea:RHEA:12240, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC ChEBI:CHEBI:16526, ChEBI:CHEBI:36658, ChEBI:CHEBI:57287,
CC ChEBI:CHEBI:57288, ChEBI:CHEBI:57384, ChEBI:CHEBI:57783,
CC ChEBI:CHEBI:58349; EC=2.3.1.165;
CC Evidence={ECO:0000269|PubMed:9003280};
CC -!- PATHWAY: Secondary metabolite biosynthesis.
CC {ECO:0000269|PubMed:25265334}.
CC -!- INDUCTION: Expression is observed in the middle of the vegetative
CC growth phase (PubMed:9438344). {ECO:0000269|PubMed:9438344}.
CC -!- DISRUPTION PHENOTYPE: Abolishes the production of terreic acid
CC (PubMed:25265334). {ECO:0000269|PubMed:25265334}.
CC -!- BIOTECHNOLOGY: Terreic acid is a metabolite with antibiotic properties
CC (PubMed:23686727). Terric acid acts also as a selective inhibitor of
CC human Bruton's tyrosine kinase in mast cells and other immune cells
CC (PubMed:10051623). {ECO:0000269|PubMed:10051623,
CC ECO:0000269|PubMed:23686727}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CH476602; EAU32819.1; -; Genomic_DNA.
DR RefSeq; XP_001215453.1; XM_001215453.1.
DR AlphaFoldDB; Q0CJ59; -.
DR SMR; Q0CJ59; -.
DR STRING; 341663.Q0CJ59; -.
DR PRIDE; Q0CJ59; -.
DR EnsemblFungi; EAU32819; EAU32819; ATEG_06275.
DR GeneID; 4322099; -.
DR VEuPathDB; FungiDB:ATEG_06275; -.
DR eggNOG; KOG1202; Eukaryota.
DR HOGENOM; CLU_000022_35_3_1; -.
DR OMA; HRRFWRT; -.
DR OrthoDB; 19161at2759; -.
DR Proteomes; UP000007963; Unassembled WGS sequence.
DR GO; GO:0004315; F:3-oxoacyl-[acyl-carrier-protein] synthase activity; IEA:InterPro.
DR GO; GO:0050641; F:6-methylsalicylic acid synthase activity; IEA:UniProtKB-EC.
DR GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR GO; GO:0031177; F:phosphopantetheine binding; IEA:InterPro.
DR GO; GO:0006633; P:fatty acid biosynthetic process; IEA:InterPro.
DR GO; GO:0044550; P:secondary metabolite biosynthetic process; IEA:UniProt.
DR Gene3D; 1.10.1200.10; -; 1.
DR Gene3D; 3.10.129.110; -; 1.
DR Gene3D; 3.40.366.10; -; 1.
DR Gene3D; 3.40.47.10; -; 1.
DR InterPro; IPR001227; Ac_transferase_dom_sf.
DR InterPro; IPR036736; ACP-like_sf.
DR InterPro; IPR014043; Acyl_transferase.
DR InterPro; IPR016035; Acyl_Trfase/lysoPLipase.
DR InterPro; IPR018201; Ketoacyl_synth_AS.
DR InterPro; IPR014031; Ketoacyl_synth_C.
DR InterPro; IPR014030; Ketoacyl_synth_N.
DR InterPro; IPR016036; Malonyl_transacylase_ACP-bd.
DR InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR InterPro; IPR032821; PKS_assoc.
DR InterPro; IPR020841; PKS_Beta-ketoAc_synthase_dom.
DR InterPro; IPR020807; PKS_dehydratase.
DR InterPro; IPR042104; PKS_dehydratase_sf.
DR InterPro; IPR013968; PKS_KR.
DR InterPro; IPR020806; PKS_PP-bd.
DR InterPro; IPR009081; PP-bd_ACP.
DR InterPro; IPR016039; Thiolase-like.
DR Pfam; PF00698; Acyl_transf_1; 1.
DR Pfam; PF16197; KAsynt_C_assoc; 1.
DR Pfam; PF00109; ketoacyl-synt; 1.
DR Pfam; PF02801; Ketoacyl-synt_C; 1.
DR Pfam; PF08659; KR; 1.
DR Pfam; PF00550; PP-binding; 1.
DR Pfam; PF14765; PS-DH; 1.
DR SMART; SM00827; PKS_AT; 1.
DR SMART; SM00826; PKS_DH; 1.
DR SMART; SM00825; PKS_KS; 1.
DR SMART; SM00823; PKS_PP; 1.
DR SUPFAM; SSF47336; SSF47336; 1.
DR SUPFAM; SSF51735; SSF51735; 2.
DR SUPFAM; SSF52151; SSF52151; 1.
DR SUPFAM; SSF53901; SSF53901; 1.
DR SUPFAM; SSF55048; SSF55048; 1.
DR PROSITE; PS00606; B_KETOACYL_SYNTHASE; 1.
DR PROSITE; PS50075; CARRIER; 1.
PE 1: Evidence at protein level;
KW Acyltransferase; Multifunctional enzyme; NADP; Oxidoreductase;
KW Phosphopantetheine; Phosphoprotein; Reference proteome; Transferase.
FT CHAIN 1..1803
FT /note="6-methylsalicylic acid synthase"
FT /id="PRO_0000437633"
FT DOMAIN 1726..1801
FT /note="Carrier"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
FT REGION 1..40
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 47..473
FT /note="Ketosynthase (KS) domain"
FT /evidence="ECO:0000255"
FT REGION 581..894
FT /note="Malonyl-CoA:ACP transacylase (MAT) domain"
FT /evidence="ECO:0000255"
FT REGION 940..1214
FT /note="Dehydrogenase (DH) domain"
FT /evidence="ECO:0000255"
FT REGION 1434..1628
FT /note="Ketoreductase (KR) domain"
FT /evidence="ECO:0000255"
FT REGION 1701..1721
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT ACT_SITE 216
FT /note="For beta-ketoacyl synthase activity"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT ACT_SITE 667
FT /note="For malonyltransferase activity"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU10022"
FT MOD_RES 1761
FT /note="O-(pantetheine 4'-phosphoryl)serine"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00258"
SQ SEQUENCE 1803 AA; 193794 MW; 302EF6DDA3A0E3C6 CRC64;
MEVHGDEVLS VDSGVSTPPS TGSGFRRPLE TPGTEIGNLN LNPQNEVAVV GMACRLAGGN
NSPEELWQSI LNRKDASGEI PSMRWEPYYR RDIRNPKILD QTTKRGYFLD HVENFDAAFF
GVSPKEAEQM DPQQRLSLEV TWEALEDAGI PPQSLSGSET AVFMGVNSDD YSKLLLEDIP
NVEAWMGIGT AYCGVPNRIS YHLNLMGPST AVDAACASSL VAIHHGRQAI LQGESEVAIV
GGVNALCGPG LTRVLDKAGA TSTEGRCLSF DEDAKGYGRG EGAAVVILKR LSTAIRDGDH
IRAIIKGSAV AQDGKTNGIM APNAKAQELV AWNALRTAGV DPLTVGYVEA HATSTPLGDP
TEVSAVSAVY GKGRPEGNPC FIGSVKPNVG HLEAGAGAVG FIKAVMAVEK AIFPPQTNLK
RLNSRIDWGQ AGVKVVQETL EWPGNEDDVR RAGVCSYGYG GTVSHAIIEE FAQQLQRPTT
NTTDEDPLPR ILLLSAPQER RLALQARTQA SWIAAEGRNR TLESIATTLS TRRGHHDYRA
AIIAENHDDA VQKLSDIVNG KAAEWTTSSR VLDASCSKDV VWVFSGHGAQ WTAMATDLLK
DIVFYQTISR LDPIVEREMG FSALHSLASG DFESSIKVQV LTYLVQVGLA AILRSKGLEP
QAVIGHSVGE IAASVAAGCL TAEEGALIVT RRANLYRRVM GAGAMVLVNI PFVDMEKELQ
GRTDLVAAID SSPSSCVVSG ATEAVLALVE DLKSRGVNAF RVKTDIPFHH PMLDQLSEPL
REAMAGSLSP RKPRVRLYST SAEDPRSMVA RDIYYWTSNM VNPVRLTAAV QAAVDDGLRL
FLEVSSHPIV SHSVRETMLD LGVEDFTVTN TMARNKPADK TILSSIAQLH CRGAVVNWKK
QLPGPWALDV PLTTWDHKPY WRHIHTGPIS ASTLHDVDKH TLLGQRVPVA GETTMVFTTQ
MDDQTKPFPG SHPLHGSEIV PAAALVNTFL HATGATTLSN ITLRVPVAIS QPRDIQVVVS
QNQIKICSRL TQKAGSGADE GSWLTHTTGQ WEAGGSKNAP AQLDIAAIKA RLANNKLADN
FSIDYLDKVG VSAMGFPWAV TEHYGTLQEM IARVDVAPDV PATSPLPWDA ASWAPILDAA
TSVGSTLFFD QPRLRMPAHI HGVQVYTTQP PLKVGYLYVE KAGDRDLAVH VSVCDELGTV
LARFESMRFS EIEGTPGSNG SEESLVHQLA WPPAIYSEKP LTINNVVLVS RDKNVADLYC
GSLKDRVSSI TVLDAAADLL SLSQDSSSVL QAKDTAVVYV PGPLHSADSI PTAAHSFLME
LLLLVKIIVN GSLPTKVFVL TDRVCESESA TALAQSPIHG VSRIIAAEHP DQWGGLIDVE
TPGQFPLETM KYVQEADNIR ISDGIPRIAR LRPLPRDKLL PPSKQTSLLP RPESTYLITG
GLGALGLEVA QFLVEKGARR LILVSRRALP PRREWADILA DASSSLAPAL ETIQALEAQG
ATVHTLAVDI SSPDAAPQLA VAIDSLSLPP VRGVVHAAGV LDSQLVLSAT SDSVERVLAP
KITGALVLGT VFPPKALDFF MLFSSCGQLL GFPGQASYAS GNAFLDAFAT SRRHQGDNAV
AVQWTSWRSL GMAASTDFIN AELASKGITD ITRDEGFRAW MHISKYDIDQ AAVLRSLAFE
ADEPLPTPIL TDIAVRKAGS ASSADAPSAA PKETNEMPES IPERRTWLDE RIRDCVARVL
QLGSSDEVDS KAALSDLGVD SVMTVSLRGQ LQKTLGVKVP PTLTWSCPTV SHLVGWFLEK
MGN